Clinical research hotspots and trends of atherosclerosis treatment with traditional Chinese medicine preparations

Author:

Li Jingyi,Wu Jiao,Xue Xiaohu,Fang Jianhe,Li Jingjing,Ao Meiying

Funder

Science and Technology Projects of Fujian Province

Education Department of Jiangxi Province

Department of Health of Jiangxi Province

Jiangxi University of Traditional Chinese Medicine

Publisher

Elsevier BV

Subject

Complementary and alternative medicine

Reference47 articles.

1. Epidemiological characteristics and the use of statins in Chinese population and simulation of lipid-lowering therapy requirement in Chinese population;Bi,2022

2. 2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care

3. Evaluation of the rationality of off-label use of thymalfas in injection based on the improved Jadad scale;Cai;Chinese Journal of Clinical Pharmacology,2020

4. Peroxisome proliferator-activated receptor γ co-activator 1-α as a critical co-activator of the murine hepatic oxidative stress response and mitochondrial biogenesis in Staphylococcus aureus sepsis;Cherry;Journal of Biological Chemistry,2014

5. Expert consensus on the clinical pathways for the atherosclerotic cardiovascular disease management in primary care in Chinese adults (proposed edition);Chinese General Practice,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3